MQ Series medical-grade MLCCs deliver reliability performance required by electronic life support applications, such as pacemakers, implantable cardioverter-defibrillators and neuromodulation devices.
AVX, a manufacturer of passive components and interconnect solutions, has released the MQ Series medical-grade MLCCs. Manufactured, tested and qualified using stringent medical design, in-process and lot acceptance requirements, MQ Series medical-grade MLCCs deliver reliability performance required by electronic life support applications, such as pacemakers, implantable cardioverter-defibrillators and neuromodulation devices. Available in several different dielectrics, case sizes, voltage and capacitance ratings, and termination options, the series offers versatility.
MQ Series medical-grade MLCCs are available in eight EIA case sizes spanning 0402 to 2225, and four dielectric materials: NP0 (C0G), X7R, X7S and X5R. Voltage ratings for the series range from 4 to 100 V, capacitance values span 1 to 100 μF, and capacitance tolerances extend from ±0.1 to ±30% pF. MQ Series capacitors are also available with four termination options: plated Ni/Sn, 60/40 Sn/Pb, 5% minimum Pb-plated solder and gold plated.
NP0 (C0G), X7R and X7S MQ Series MLCCs are rated for operating temperatures spanning -55° to +125° C. Operating temperatures for X5R MQ Series MLCCs range from -55° to +85° C. MQ Series capacitors in 0402, 1210, 1812, 1825 and 2225 cases are compatible with reflow soldering, and 0603, 0805 and 1206 cases are compatible with both reflow and wave.
Components can be purchased directly from AVX, and they are shipped on 7 or 13 in. reels or in waffle packaging. Lead-time for the series is 15 weeks. MQ Series medical-grade MLCCs are manufactured and reliability and performance tested at AVX’s Myrtle Beach, South Carolina facility, which is TS 16949 certified.
AVX
www.avx.com
